Terumo Corporation
Explore this company’s associated devices, FDA decisions and regulatory history.

Terumo Corporation
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Terumo Corporation. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Mar 27, 2026 to Mar 27, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LOX appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 44-1, 2-Chome, Hatagaya, Shibuya-Ku, Tokyo, 151-0072, JP. Recorded on K252295, decision dated Mar 27, 2026.
Device categories in this collection
Catheters, Transluminal Coronary Angioplasty, Percutaneous.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
Ryurei
K252295 · 510(k) clearance
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.